首页> 美国卫生研究院文献>Neuro-Oncology >EPT-22TREATMENT OF CHILDREN WITH PRIMARY CNS TUMORS AND LEPTOMENINGEAL DISSEMINATED AND/OR MULTICENTRIC DISEASE IN PHASE II STUDIES WITH ANTINEOPLASTONS A10 AND AS2-1

【2h】

EPT-22TREATMENT OF CHILDREN WITH PRIMARY CNS TUMORS AND LEPTOMENINGEAL DISSEMINATED AND/OR MULTICENTRIC DISEASE IN PHASE II STUDIES WITH ANTINEOPLASTONS A10 AND AS2-1

机译：EPT-22治疗儿童的原始CNS肿瘤和II期研究的抗肿瘤塑料A10和AS2-1的全脑弥散和/或多中心疾病

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Neuro-Oncology
作者
Stanislaw Burzynski; Tomasz Janicki; Gregory Burzynski;
展开▼
作者单位

展开▼
年(卷),期 2016(18),Suppl 3
年度 2016
页码 iii28–iii29
总页数 1
原文格式 PDF
正文语种
中图分类神经病学;肿瘤学;
关键词

相似文献

外文文献
中文文献

1. Primary CNS Tumors and Leptomeningeal, Disseminated and/or Multicentric Disease in Children Treated in Phase II Studies with Antineoplastons A10 and AS2-1 [J] . Stanislaw Burzynski, Tomasz Janicki, Gregory Burzynski Cancer and Clinical Oncology . 2016,第2期

机译：在II期研究中使用抗neoplaston A10和AS2-1治疗的儿童的原发性中枢神经系统肿瘤和软脑膜，弥散性和/或多中心疾病
2. A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Recurrent, Refractory or Progressive Primary Brain Tumors—Final Report (Protocol BT-22) [J] . Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Journal of Cancer Therapy . 2014,第10期

机译：患有复发性，难治性或进行性原发性脑肿瘤的儿童抗neoplaston A10和AS2-1的II期研究—最终报告（协议BT-22）
3. A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients with Primary Brain Tumors—Final Report (Protocol BT-09) [J] . Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski Journal of Cancer Therapy . 2015,第12期

机译：成年原发性脑肿瘤患者抗neoplaston A10和AS2-1的II期研究—最终报告（协议BT-09）
4. Global Picture on Children's Asthma and Allergic Diseases and Their Home Environment-'Children-Health-Homes; Phase Ⅰ Study [C] . Yuexia Sun, Malin Larsson, Kiril Naydenov, Annual conference of the International Society of Exposure Science . 2014

机译：关于儿童哮喘和过敏性疾病及其家庭环境的全球图景-“儿童保健之家”; Ⅰ期研究
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma [O] . Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, -1

机译：基于脑干神经胶质瘤患者A10和AS2-1抗肿瘤药Ⅱ期研究的复发性弥漫性桥脑内胶质瘤儿童的反应和生存
7. A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Recurrent, Refractory or Progressive Primary Brain Tumors—Final Report (Protocol BT-22) [O] . Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, 2014

机译：AIT II研究患有复发性，难治性或渐进原发性脑肿瘤的儿童的抗肿瘤孢子A10和AS2-1 - 最终报告（协议BT-22）

EPT-22TREATMENT OF CHILDREN WITH PRIMARY CNS TUMORS AND LEPTOMENINGEAL DISSEMINATED AND/OR MULTICENTRIC DISEASE IN PHASE II STUDIES WITH ANTINEOPLASTONS A10 AND AS2-1

著录项

相似文献

相关主题

期刊订阅